.png?width=261&name=2021_newest_logo_cola-footer%20(1).png){kind=logo}
.jpg)
For the past 25 years, the recommendation for Lyme Disease testing has been a two-test methodology, enzyme immunoassay (EIA) or immunofluorescence test followed by a western immunoblot assay performed on those specimens yielding a positive or equivocal Lyme Disease EIA result.
